cyclotraxin b (MedChemExpress)
Structured Review
Cyclotraxin B, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-p1178/Cyclotraxin+B/bio_rxiv__2025__11__18__689087-187-32-40
Average 93 stars, based on 6 article reviews
Images
Related Articles
Microinjection:Article Title: Alteration of neural activity and neuroinflammatory factors in the insular cortex of mice with corneal neuropathic pain. Article Snippet: .. The Article Title: Alteration of neural activity and neuroinflammatory factors in the insular cortex of mice with corneal neuropathic pain. Article Snippet: .. The Saline:Article Title: Alteration of neural activity and neuroinflammatory factors in the insular cortex of mice with corneal neuropathic pain. Article Snippet: .. The Article Title: Alteration of neural activity and neuroinflammatory factors in the insular cortex of mice with corneal neuropathic pain. Article Snippet: .. The other:Article Title: Dissection of signaling pathways regulating TrkB-dependent gephyrin clustering. Article Snippet: At DIV14, the cells were washed and treated with 145 mM NaCl, 2 mM KCl, 2 mM CaCl, 2 mM MgCl, 10 mM Glucose, 10 mM HEPES (Pennacchietti et al., 2017) supplemented with 20 μM NMDA and 10 μM Article Title: Dissection of signaling pathways regulating TrkB-dependent gephyrin clustering Article Snippet: At DIV14, the cells were washed and treated with 145 mM NaCl, 2 mM KCl, 2 mM CaCl, 2 mM MgCl, 10 mM Glucose, 10 mM HEPES ( ) supplemented with 20 μM NMDA and 10 μM Activity Assay:Article Title: Alteration of neural activity and neuroinflammatory factors in the insular cortex of mice with corneal neuropathic pain. Article Snippet: .. The |
![NHQXW regulated the <t>TrkB/ERK/CREB</t> pathway in the hippocampus of CCS mice. The results were presented in 4 groups: vehicle-treated normal control group, CORT stress group, stress plus NQHXW treatment groups at a dosage of 20 mg/kg, and FLX treatment group. The sample size for all groups was 4-5. (A) Representative immunoblot results for the expression of BDNF, TrkB, p-ERK (T202/T204), p-MEK1/2 (S217/221), and p-CREB (S133). (B–F) Quantification of the relative expression for the ratio of BDNF/β-actin (B) , TrkB/β-actin (C) , p-MEK1/2 (S217/221)/total MEK1/2 (D) , p-ERK (T202/T204)/total ERK (E) , and p-CREB (S133)/total CREB (F) [F (3,15) = 19.35, p < 0.0001 for BDNF analysis; F (3,15) = 8.858, p = 0.0013 for TrkB analysis; F (3,15) = 10.38, p = 0.0006 for p-MEK (S217/221) analysis; F (3,15) = 45.21, p < 0.0001 for p-ERK (T202/T204) analysis; F (3,15) = 18.72, p < 0.0001 for p-CREB(S133) analysis]. Data are presented as mean ± S.E.M.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_8638/pmc10808638/pmc10808638__fphar-14-1274343-g005.jpg)
